EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian hamsters

Juan García-Bernalt Diego, Gagandeep Singh, Sonia Jangra, Kim Handrejk, Manon Laporte, Lauren A Chang, Sara S El Zahed, Lars Pache, Max W Chang, Prajakta Warang, Sadaf Aslam, Ignacio Mena und 4 weitere

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1011805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Juan García-Bernalt Diego und 15 weiteren Autor:innen. Beteiligte Einrichtung: Infectious and Tropical Diseases Research Group (e-INTRO), Biomedical Research Institute of Salamanca-Research Centre for Tropical Diseases at the Un…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hybrid immunity (vaccination + natural infection) to SARS-CoV-2 provides superior protection to re-infection. We performed immune profiling studies during breakthrough infections in mRNA-vaccinated hamsters to evaluate hybrid immunity induction. The mRNA vaccine, BNT162b2, was dosed to induce binding antibody titers against ancestral spike, but inefficient serum virus neutralization of ancestral SARS-CoV-2 or variants of concern (VoCs). Vaccination reduced morbidity and controlled lung virus titers for ancestral virus and Alpha but allowed breakthrough infections in Beta, Delta and Mu-challenged hamsters. Vaccination primed for T cell responses that were boosted by infection. Infection back-boosted neutralizing antibody responses against ancestral virus and VoCs. Hybrid immunity resulted in more cross-reactive sera, reflected by smaller antigenic cartography distances. Transcriptomics post-infection reflects both vaccination status and disease course and suggests a role for interstitial macrophages in vaccine-mediated protection. Therefore, protection by vaccination, even in the absence of high titers of neutralizing antibodies in the serum, correlates with recall of broadly reactive B- and T-cell responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19AnimalsCricetinaeHumansBNT162 VaccineBreakthrough InfectionsMesocricetusAntibodies, NeutralizingPostoperative ComplicationsRNA, MessengerImmunityAntibodies, ViralVaccination

Substanzen

BNT162 VaccineAntibodies, NeutralizingRNA, MessengerAntibodies, Viral

Autor:innen und Institutionen

  • Infectious and Tropical Diseases Research Group (e-INTRO), Biomedical Research Institute of Salamanca-Research Centre for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University…
  • Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • NCI Designated Cancer Center, Sanford-Burnham Prebys Medical Discovery Institute, La Jolla, California, United States of America.
  • Department of Medicine, University of California San Diego, La Jolla, California, United States of America.

ORCID-Profile: Michael Schotsaert

Förderung

  • NIAID NIH HHS
  • NIDDK NIH HHS
  • NIH HHS
  • Center for Research on Influenza Pathogenesis and Transmission
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Friedrich-Alexander-Universität Erlangen-Nürnberg
  • Foundation for the National Institutes of Health

Zitieren

APA

Diego, J. G., Singh, G., Jangra, S., Handrejk, K., Laporte, M., Chang, L. A., El Zahed, S. S., Pache, L., Chang, M. W., Warang, P., Aslam, S., Mena, I., Webb, B. T., Benner, C., García-Sastre, A., & Schotsaert, M. (2024). Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian hamsters. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011805

Vancouver

Diego JG, Singh G, Jangra S, Handrejk K, Laporte M, Chang LA, et al. Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian hamsters. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1011805

BibTeX
@article{Diego2024,
  author = {Diego, Juan García-Bernalt and Singh, Gagandeep and Jangra, Sonia and Handrejk, Kim and Laporte, Manon and Chang, Lauren A and El Zahed, Sara S and Pache, Lars and Chang, Max W and Warang, Prajakta and Aslam, Sadaf and Mena, Ignacio and Webb, Brett T and Benner, Christopher and García-Sastre, Adolfo and Schotsaert, Michael},
  title = {Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian hamsters},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1011805}
}
Kostenlos starten →